Press "Enter" to skip to content

New patent expiration for IPR drug CRESTOR

2
Copyright © DrugPatentWatch. Originally published at New patent expiration for IPR drug CRESTOR

Annual Drug Patent Expirations for CRESTOR
Annual Drug Patent Expirations for CRESTOR

Crestor is a drug marketed by IPR and is included in one NDA. It is available from four suppliers. There are two patents protecting this drug and one Paragraph IV challenge.

CRESTOR drug price trends.

Drug patent litigation for CRESTOR.

The generic ingredient in CRESTOR is rosuvastatin calcium. Four suppliers are listed for this compound. Additional details are available on the rosuvastatin calcium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for IPR drug CRESTOR
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions